UZ Leuven - Campus Gasthuisberg
About UZ Leuven - Campus Gasthuisberg
Universitair Ziekenhuis Leuven, often shortened to UZ Leuven, is an academic hospital in Leuven, Belgium, associated with the university KU Leuven. It consists of five campuses as of 2016; Gasthuisberg, Lubbeek, Pellenberg, Sint-Pieter and Sint-Rafaël. The hospital has 1,995 beds and over 9,000 employees.
There are 1,995 beds in UZ Leuven - Campus Gasthuisberg.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
24
European Organisation for Research and Treatment of Cancer - EORTC
24
Amgen
14
Vertex Pharmaceuticals Incorporated
13
Pfizer
9
Celgene
7
Medtronic Cardiac Rhythm and Heart Failure
5
Regeneron Pharmaceuticals
4
Loxo Oncology, Inc.
3
University Hospital, Gasthuisberg
3
AstraZeneca
2
Clinical Trials at UZ Leuven - Campus Gasthuisberg
During the past decade, UZ Leuven - Campus Gasthuisberg conducted 134 clinical trials. In the 10-year time frame, 134 clinical trials started and 40 clinical trials were completed, i.e. on
average, 29.9% percent of trials that started reached the finish line to date. In the past 5 years, 42 clinical trials started and 27 clinical trials were completed. i.e. 64.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Radiation Therapy or Temozolomide in Treating Patients With Gliomas
2005-07-01
2014-05-01
Completed
709
To Assess The Efficacy and Safety Of Oral Sildenafil in the Treatment of Pulmonary Arterial Hypertension.
2008-04-08
2010-05-25
Terminated
130
Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients
2008-08-01
2015-06-01
Completed
178
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
2011-03-01
2021-12-01
Unknown status
1,000
Evaluation of Adding Small Amounts of Oxygen to the CO2 Pneumoperitoneum Upon Pain and Inflammation
2008-05-01
2010-08-01
Completed
60
Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma
2008-08-21
2016-07-14
Completed
1,623
FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer
2006-08-01
2015-05-01
Completed
530
A Study to Determine the Efficacy and Safety of Lenalidomide in Patients With Mantle Cell NHL Who Have Relapsed or Progressed After Treatment With Bortezomib or Are Refractory to Bortezomib. The "EMERGE" Trial
2008-12-22
2017-11-08
Completed
134
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "UZ Leuven - Campus Gasthuisberg" #1 sponsor was "Eli Lilly and Company" with 24 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 24 trials
sponsored, "Amgen" with 14 trials sponsored, "Vertex Pharmaceuticals Incorporated" with 13 trials sponsored and "Pfizer"
with 13 trials sponsored. Other sponsors include 84 different institutions and
companies that sponsored additional 69 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "UZ Leuven - Campus Gasthuisberg"
#1 collaborator was "Eli Lilly and Company" with 6 trials as a collaborator, "UNICANCER" with 3 trials as a collaborator, "ADIR, a Servier Group company" with 2 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator and "Bayer" with 2 trials as a collaborator. Other collaborators include 55 different institutions and companies that were
collaborators in the rest 55 trials.
Clinical Trials Conditions at UZ Leuven - Campus Gasthuisberg
According to Clinical.Site data, the most researched conditions in "UZ Leuven - Campus Gasthuisberg" are
"Cystic Fibrosis" (13 trials), "Ulcerative Colitis" (8 trials), "Metastatic Breast Cancer" (6 trials), "Breast Cancer" (5 trials) and "Crohn's Disease" (5 trials). Many other conditions were trialed in "UZ Leuven - Campus Gasthuisberg" in a lesser frequency.
Clinical Trials Intervention Types at UZ Leuven - Campus Gasthuisberg
Most popular intervention types in "UZ Leuven - Campus Gasthuisberg" are "Drug" (130 trials), "Other" (24 trials), "Device" (15 trials), "Biological" (9 trials) and "Procedure" (9 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (36 trials), "IVA" (13 trials), "ELX/TEZ/IVA" (8 trials), "Abemaciclib" (5 trials) and "TEZ/IVA" (5 trials). Other intervention names were less common.
Clinical Trials Genders at UZ Leuven - Campus Gasthuisberg
The vast majority of trials in "UZ Leuven - Campus Gasthuisberg" are
146 trials for "All" genders, 20 trials for "Female" genders and 7 trials for "Male" genders.
Clinical Trials Status at UZ Leuven - Campus Gasthuisberg
Currently, there are NaN active trials in "UZ Leuven - Campus Gasthuisberg".
undefined are not yet recruiting,
45 are recruiting,
34 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 70 completed trials in UZ Leuven - Campus Gasthuisberg,
undefined suspended trials,
and 14 terminated clinical trials to date.
Out of the total trials that were conducted in UZ Leuven - Campus Gasthuisberg, 26 "Phase 1"
clinical trials were conducted, 39 "Phase 2" clinical
trials and 80 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 16 trials that are defined as “Not Applicable".